Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Prognostic factors in non-small cell lung cancer. | Front Oncol | 2023 | 36998444 | PubTator, text mining | PubMed |
| SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128. | Viruses | 2023 | 36992331 | PubTator, text mining | PubMed |
| Spatial multiomics map of trophoblast development in early pregnancy. | Nature | 2023 | 36991123 | PubTator, text mining | PubMed |
| FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m6A Modification and Necroptosis. | Genes (Basel) | 2023 | 36981005 | PubTator, text mining | PubMed |
| Demystifying the Role of Prognostic Biomarkers in Breast Cancer through Integrated Transcriptome and Pathway Enrichment Analyses. | Diagnostics (Basel) | 2023 | 36980449 | PubTator, text mining | PubMed |
| A custom-made AAV1 variant (AAV1-T593K) enables efficient transduction of Japanese quail neurons in vitro and in vivo. | Commun Biol | 2023 | 36977781 | PubTator, text mining | PubMed |
| Transcriptional drifts associated with environmental changes in endothelial cells. | Elife | 2023 | 36971339 | PubTator, text mining | PubMed |
| CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma. | BMC Cancer | 2023 | 36959566 | PubTator, text mining | PubMed |
| Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration. | Cancer Med | 2023 | 36952458 | PubTator, text mining | PubMed |
| Relationship between the deep features of the full-scan pathological map of mucinous gastric carcinoma and related genes based on deep learning. | Heliyon | 2023 | 36942252 | PubTator, text mining | PubMed |
| Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools. | Medicine (Baltimore) | 2023 | 36930083 | PubTator, text mining | PubMed |
| Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma. | World J Surg Oncol | 2023 | 36927438 | PubTator, text mining | PubMed |
| Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 36915467 | PubTator, text mining | PubMed |
| Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing's sarcoma. | Front Oncol | 2023 | 36910645 | PubTator, text mining | PubMed |
| Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes. | Front Pharmacol | 2023 | 36909154 | PubTator, text mining | PubMed |
| Classification of COVID-19 Patients into Clinically Relevant Subsets by a Novel Machine Learning Pipeline Using Transcriptomic Features. | Int J Mol Sci | 2023 | 36902333 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis. | Diagnostics (Basel) | 2023 | 36900109 | PubTator, text mining | PubMed |
| Immune subset-committed proliferating cells populate the human foetal intestine throughout the second trimester of gestation. | Nat Commun | 2023 | 36899020 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| Non-canonical functions of SNAIL drive context-specific cancer progression. | Nat Commun | 2023 | 36882420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=17